Fusion Antibodies gears up for flotation on the AIM

The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

Share the Post:

Related Posts

CFM and Ilimex

ILIMEX Announces Conclusion of Funding Round Raising £600,000 (c.€700,000) In Equity Finance

ILIMEX, the Northern Ireland-based provider of biosecurity and air sterilisation solutions, is pleased to announce the conclusion of a funding round which has raised additional equity finance of £600,000 (c. €700,000). This funding will be used to validate the performance of ILIMEX’s Flufence air sterilisation solutions and fund its entry into the agri-food sector with an initial focus on poultry and medicinal mushroom production.

Read More